The Chronic Myelocytic Cell Line K562 Contains a Breakpoint in BCR and Produces a Chimeric BCR/C-Abl Transcript.

Molecular and Cellular Biology - United States
doi 10.1128/mcb.6.2.607
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

E19a2 BCR-ABL Fusion Transcript in Typical Chronic Myeloid Leukaemia: A Report of Two Cases

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Bcr: A Negative Regulator of the BCR-Abl Oncoprotein in Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

MT1-MMP as a Downstream Target of BCR-ABL/ABL Interactor 1 Signaling: Polarized Distribution and Involvement in BCR-ABL-stimulated Leukemic Cell Migration

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

How to Detect the Rare BCR‑ABL (E14a3) Transcript: A Case Report and Literature Review

Oncology Letters
Cancer ResearchOncology
2017English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Re-Evaluating the Role of BCR/ABL in Chronic Myelogenous Leukemia

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2014English

Semi‑random Mutagenesis Profile of BCR‑ABL During Imatinib Resistance Acquirement in K562 Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy